The current results revealed the KRas engagement of NSC290956 in intact cells by thermally stabilizing KRas (Figure 3D), further blocking the cellular KRas activity (Figure 4) and resulting in a degree of KRas-dependent lethality in NSCLC tumor cells (Figure 5A). Here, KRAS is linked to neoplasm.